IDELVION albutrepenonacog alfa 3500 IU powder (and diluent) for injection

Land: Australië

Taal: Engels

Bron: Department of Health (Therapeutic Goods Administration)

Werkstoffen:

Factor IX, Quantity: 3500 IU

Beschikbaar vanaf:

CSL Behring Australia Pty Ltd

farmaceutische vorm:

Solution

Samenstelling:

Excipient Ingredients:

Toedieningsweg:

Intravenous

Eenheden in pakket:

3500 IU

Prescription-type:

Not scheduled. Not considered by committee

therapeutische indicaties:

IDELVION is indicated in all patients with haemophilia B for:,? Routine prophylaxis to prevent or reduce the frequency of bleeding episodes,? Control and prevention of bleeding episodes,? Control and prevention of bleeding in the perioperative setting.

Product samenvatting:

Visual Identification: Clear solution; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 3 Years; Container Temperature: Store between 2 - 25 degrees celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Autorisatie-status:

Registered

Autorisatie datum:

2020-11-19